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Abstract
Objective—To assess the impact of a managed care-based patient reminder/recall system on 
immunization rates and preventive care visits among low-income adolescents.
Methods—We conducted a randomized controlled trial between December 2009 and December 
2010 that assigned adolescents aged 11–17 years to one of three groups: mailed letter, telephone 
reminders, or control. Publicly insured youths (n = 4, 115) were identified in 37 participating 
primary care practices. The main outcome measures were immunization rates for routine vaccines 
(meningococcus, pertussis, HPV) and preventive visit rates at study end.
Results—Intervention and control groups were similar at baseline for demographics, 
immunization rates, and preventive visits. Among adolescents who were behind at the start, 
immunization rates at study end increased by 21% for mailed (P < .01 vs control), 17% for 
telephone (P < .05), and 13% for control groups. The proportion of adolescents with a preventive 
visit (within 12 months) was: mailed (65%; P <.01), telephone (63%; P <.05), and controls (59%). 
The number needed to treat for an additional fully vaccinated adolescent was 14 for mailed and 25 
for telephone reminders; for an additional preventive visit, it was 17 and 29. The intervention cost 
$18.78 (mailed) or $16.68 (phone) per adolescent per year to deliver. The cost per additional 
adolescent fully vaccinated was $463.99 for mailed and $714.98 for telephone; the cost per 
additional adolescent receiving a preventive visit was $324.75 and $487.03.
Conclusions—Managed care-based mail or telephone reminder/recall improved adolescent 
immunizations and preventive visits, with modest costs and modest impact.
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Introduction
Between 2005 and 2006, 3 new vaccines were added to the recommended immunization 
schedule for adolescents: pertussis vaccine (Tdap), meningococcal vaccine (MCV4), and 
human papillomavirus vaccine (HPV).1,2 Unfortunately, adolescent immunization rates are 
suboptimal. In 2010, national coverage rates for adolescents 13 to 17 years was 69% for 
Tdap, 63% for MCV4 vaccine, and, among girls, 49% for ≥1 dose of HPV vaccine and 32% 
for ≥3 doses of HPV vaccine.3 Furthermore, some disparities exist, with minority 
adolescents having lower completion rates of 3 doses of HPV vaccine.4
Experts,5–8 including the Task Force on Community Preventive Services,9–11 recommend 
that primary care practices use mailed or telephone reminder/recall to encourage 
immunizations for patients of all ages; reminder messages target upcoming immunizations 
whereas recall messages target overdue immunizations. These recommendations are 
primarily based on studies of young children, published before the routine recommendations 
for adolescent immunization with Tdap, MCV4, and HPV vaccines; these studies noted 
improved childhood immunization rates due to practice-based reminder/recall.6,7,10 Because 
adolescents present infrequently for primary health care visits,5,12 reminder/recall for 
adolescent immunizations is attractive in concept.13,14
Nevertheless, little evidence exists for the effectiveness of practice-based reminder/recall for 
adolescent immunizations,15,16 although in one recent study in 4 practices researchers 
demonstrated increased immunization rates.17 Moreover, few practices actually use 
reminder/recall for patients of any age18–20; barriers include the added workload, costs, and 
complexities of conducting such a program.21,22 Furthermore, some recent studies targeting 
low-income populations found little or no benefit to practice-based reminder/recall for 
young children because of difficulties in reaching families that often change addresses or 
telephone numbers.18,23–26 Although tiered interventions that combine reminder/recall with 
outreach have improved immunization rates among low-income populations,16,27–30 they 
are somewhat costly. In sum, practice-based reminder/recall, although recommended, is 
underused and has not yet achieved its promise.
A model that has not been well studied is centralized reminder/recall, ie, having messages 
generated by health systems such as managed care organizations that are associated with 
multiple primary care practices. Most children and adolescents are now enrolled in managed 
care plans31 and health reform will result in increased enrollment in centralized 
organizations.32 Centralized systems can take advantage of economies of scale and new 
technology such as autodialer systems that can broadcast hundreds of telephone reminders in 
a short time. Managed care organizations are interested in immunization and preventive care 
visit rates, which are Healthcare Effectiveness Data and Information Set (HEDIS) quality 
measures.33–37 However, managed care organizations may not have accurate family contact 
information and families may not respond to reminders emanating from managed care plans.
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We conducted a randomized controlled trial, based in a large managed care organization, to 
evaluate the effectiveness of a centralized reminder/recall system on improving rates of 
immunization and preventive care visits among low-income adolescents. We also compared 
the effectiveness of mailed versus telephone reminders. We hypothesized that centralized 
reminder/recall would improve immunization rates, with telephone calls being most 
effective because they appear more personal.
Methods
Setting
The study was based at the Monroe Plan for Medical Care, a not-for-profit managed care 
organization in upstate New York serving 72,404 publicly insured children and adolescents 
covered by Medicaid or the NY State Child Health Insurance Program.
Study Design
We conducted a 1-year randomized, controlled comparative effectiveness trial, comparing 
mailed reminder versus telephone reminder versus standard of care control (December 11, 
2009, through December 12, 2010). We randomized adolescents within each practice to one 
of the 3 groups, allocating siblings to the same group. The Research Subjects Review Board 
of the University of Rochester approved the study. Parent informed consent was not 
required, but parents and practices could opt out at any time.
Participants
Primary Care Practices—From the Monroe Plan’s dataset of practices in 15 upstate 
counties, we selected all primary care practices that served ≥30 adolescents covered by the 
Monroe Plan in December 2009 (range of 35 to 1308). One of 38 eligible practices dropped 
out of the study, leaving 37 practices (22 pediatric, 13 family medicine, 2 internal medicine 
practices), which served 9369 adolescents. Nineteen practices had 1 doctor, 3 had 2 doctors, 
2 had 3 doctors, and 13 had ≥4 physicians. We surveyed the practices about their baseline 
use of reminders. Of the 24 practices that responded, 12 (50%) used telephone or mailed 
reminders for adolescents who had scheduled preventive care visits, and 6 (25%) used 
telephone or mailed reminders for patients behind in at least some vaccines. Because 
adolescents were randomized within each practice, any impact of these practice-level 
reminders would be identical across study groups.
Subjects—The target population was all adolescents ages 10.5 through 17 years enrolled 
in Monroe Plan on December 31, 2009, with a primary care provider in a participating 
practice. We used 10.5 years as the lower age to provide time to generate reminders and for 
parents to make appointments for immunizations or preventive visits after age 11. Prior to 
randomization, we excluded (a) adolescents enrolled in the Monroe Plan for <6 months (due 
to insufficient data on prior healthcare or immunizations) and (b) adolescents with a 
contraindication (eg, anaphylaxis caused by vaccination) listed on claims files (n = 1). 
Adolescents who disenrolled from the managed care plan stopped receiving reminders if 
assigned to a study group but remained in the analytic sample for assessment of outcomes 
(90% were continuously enrolled throughout the intervention period).
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Because the Monroe Plan enrollment files did not include family-level data, we identified 
adolescents who appeared to reside in the same household using address standardization and 
geo-coding software (Pitney Bowes Business Insight MapMarker USA, Version 22).
Randomization
We randomly selected a referent adolescent and randomly assigned them (and age-eligible 
siblings) to 1 of the 2 intervention groups or the control group (by AB, using Stata 9.2) 
stratifying on practice, age in years, and gender (Fig. 1). Health care providers were unaware 
of group assignment. Thus, by design the 3 study groups were balanced in numbers of 
adolescents and age/gender of the index adolescent across all practices.
After randomization, we realized that the managed care database often lacked a household 
telephone number (41%) (neither a land line nor a cell phone was noted) or a geocodable 
address (3.6%). Because we wished to target the intervention to families who could possibly 
respond to either a telephone or mailed reminder, we excluded from the main analysis any 
adolescent for whom the managed care plan’s database lacked either a household telephone 
number or geocodable household address. This also allowed us to assess the potential 
“reach”38 of the intervention— ie, the proportion of enrollees who could in the real world be 
targeted for the intervention. As a secondary analysis, we reanalyzed the results for all 
randomized adolescents (even if no telephone or address).
Study Interventions
Identifying Adolescents Eligible for Immunizations or Preventive Visits—
Adolescents were considered eligible for a preventive care visit if they had none recorded 
for ≥14 months. We defined adolescents as eligible for Tdap, MCV4, or HPV vaccine based 
on 2010 ACIP guidelines3: Tdap if no previous Tdap or Td vaccine within 2 years (most 
practices used this timeframe between Tdap and Td vaccines); MCV4 if no previous 
vaccine; and HPV vaccine for girls (HPV1 if none previous, HPV2 if >60 days from HPV1, 
and HPV3 if >24 weeks from HPV1 and >12 weeks from HPV2). We did not include 
varicella vaccine because of the complexity of determining previous disease or vaccine 
eligibility,39 or influenza vaccine because of its special seasonality.
The managed care organization developed an automatic algorithm that reviewed vaccination 
and preventive care visit measures every 5 weeks and triggered a reminder (starting at 10.8 
years) if eligible. Mail and telephone reminders informed parents that they could opt out of 
future reminder/recall messages or could call the managed care plan with concerns.
Mailed Reminders—The managed care organization sent reminder letters advising 
parents to call their adolescent’s primary care practice to schedule an appointment. The 
letters provided the practice’s telephone number. Letters were sent at 10-week intervals for 
Tdap, MCV4, and preventive care visits (maximum of 5 reminders over 12 months). For 
HPV, the plan sent the letter for the first vaccine at 10-week intervals and reminders for 
HPV2 or HPV3 at 5-week intervals (maximum 8 reminders per vaccine dose). Letters were 
written in English and Spanish (2-sided), and tested (Flesch-Kinkaid software) as <7th-grade 
reading level. Letters stated they were sent on behalf of the child’s insurance company and 
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primary care practice, and they specified the practice name, child age, and specific services 
recommended (specific vaccines or preventive visit). No patient names were included in 
order to match the content to the telephone reminders.
Telephone Reminders—Telephone reminders were sent at the same frequency as letters 
by an autodialer service in which a recorded human voice in English or Spanish was used, 
with a message that mirrored the information in the letter reminders. No patient names were 
included due to HIPAA requirements.
Controls—These adolescents received standard of care from each respective practice.
Data Sources
Patient Information—The managed care organization’s enrollment files identified 
adolescent names, addresses, telephone numbers, birthdates, gender, type of insurance 
(Medicaid managed care, NY State Child Health Insurance Program), and primary care 
practice. Race/ethnicity was unavailable. Of note, the managed care organization obtained 
the telephone numbers and addresses for Medicaid managed care enrollees from the New 
York State Medicaid enrollment files; in 41% of cases this download resulted in missing 
telephone numbers.
Vaccinations and Preventive Visits—The managed care organization’s claims files 
identified vaccinations received (Current Procedural Terminology codes) and preventive 
care visits (International Classification of Diseases 9 codes). To obtain accurate vaccination 
information, the plan merged data from their claims records with data from the NYS 
Immunization Information System (immunization registry) and based vaccination reminders 
upon this merged database.
Measures
Primary Measures—Main outcomes were receipt of (1) each vaccination (Tdap, MCV4, 
and HPV1,2,3 for girls) on or after age 11 years, (2) all vaccinations combined, and (3) a 
preventive visit during the 12-month period. Preventive visits were defined as 
comprehensive visits focused on routine preventive care; immunization-only visits were not 
counted. We also measured the time to vaccination since January 1, 2009 (1 year before the 
intervention started). The primary independent variable was group assignment (mailed 
reminder, telephone reminder, control).
Secondary Outcome Measures—We assessed process measures for mailed reminders 
(returned letters) and telephone reminders (line busy, answered by person, answering 
machine, no answer) and recorded the number of parents who opted out. We also assessed 
missed opportunities (primary care visits during which a vaccine was due but not 
administered), for any type of primary care visit since the start of the intervention. We 
calculated the number needed to treat (ie, to remind) to be fully vaccinated for all 3 vaccines 
and also to receive a preventive visit during the year. Finally, we measured costs of the 
intervention by summing the total personnel and non-personnel costs and calculating costs 
per year, adjusting costs to 2011 US dollar values. Wages for project personnel were based 
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on the national mean (hourly wage) value for the appropriate job categories using data from 
the 2011 US Bureau of Labor Statistics Occupational Employment and Wage Estimates.40
Statistical Analyses
We determined the hazard ratio of receipt of vaccinations or a preventive care visit at the 
end of the study for mailed versus control, telephone versus control, and mailed versus 
telephone groups. We used a clustered stratified Cox proportional hazard regression model 
with Efron’s method to handle tied events and the Huber/White variance estimator 
clustering on households and stratifying on sample stratification variables (age, gender, 
practice). This model accounts for the 22% of subjects who were not enrolled for the entire 
year before and the entire year during the intervention. For analyses where the outcome was 
time to vaccination, we measured time from January 1, 2009, and included study group 
(mailed, telephone, control), an indicator for intervention time period, and an interaction 
between the 2 independent variables in the models. For the preventive care visit analysis, we 
ran separate models for the baseline and intervention time periods, and included an 
independent variable indicating if the child had a preventive visit within 12 months. The 
beginning time period for both models was January 1st of each year. (StataMP, Version 
12.0).41
We performed a prespecified subgroup analysis on age, gender, insurance, and practice 
subgroups for the composite immunization and preventive care outcomes. We performed a 
second analysis that included all adolescents regardless of lack of telephone numbers or 
addresses to assess the intervention impact at the managed care organization level. To 
control for multiple testing, we adjusted confidence intervals for the 16 tests for the 
composite immunization outcome and 18 tests for preventive visits using Šidák’s method.42 
The study had >90% power for a 5% improvement in immunization rates at study end 
assuming 50% for controls (two-sided alpha = 0.05), using survival analysis and an 
intention-to-treat analysis.
We used descriptive statistics to summarize process measures and costs per adolescent per 
year. We calculated the cost-effectiveness for becoming vaccinated or receiving a preventive 
visit as the total cost of the intervention divided by: ([no. subjects] × [difference in the%of 
the outcome between study and control groups]).43
Results
Randomization
In total, 7404 adolescents from 5559 families were randomized into 3 groups (Fig. 1); 3289 
(44%) subjects lacked a telephone number or geocodable address, leaving 4115 adolescents 
(1296 control, 1396 mailed, and 1423 telephone reminder). Of these households, 73% had 
one adolescent, 22% had 2 and 5% had 3 or more.
Baseline Characteristics
The control and intervention groups had similar demographics (Table 1) and baseline 
immunization and preventive visit rates. The mean age at the start of the study was 14.4 
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years (SD 2.0). Baseline immunization rates closely mirrored national rates.4 Of note, 
baseline immunization rates were not significantly different for the adolescents with or 
without telephone numbers or geocodable addresses.
Immunization Rates
Table 2 shows immunization rates at the end of the study for adolescents who were not up-
to-date for the given vaccine at the study outset. Immunization rates for individual vaccines 
and for all vaccines combined were 4–9 percentage points greater for the mailed and 
telephone reminder groups compared with the control group, with hazard ratios ranging 
from 1.1 to 1.6 (P < .05 for most comparisons). Among adolescents missing any vaccination 
at study outset, 21% of mailed reminder, 17% of telephone reminder, and 13% of control 
group adolescents received all vaccinations by the end of the study period. Results for the 
mailed versus telephone reminders were not significantly different. Irrespective of the type 
of intervention, relatively few adolescents who had been behind at the start were vaccinated 
by the end of the study. The number needed to treat (ie, to remind) for an additional 
adolescent to be fully vaccinated was 14 for mailed reminders and 25 for telephone 
reminders.
Table 3 shows immunization rates at the end of the study, for all ages and all vaccines 
combined, for all adolescents, regardless of whether they were up-to-date at the beginning of 
the study. Among adolescents with any telephone number or geocodable address, overall 
immunization rates at the end of the study were 56% for mailed reminder group, 53% for the 
telephone reminder group, and 50% for controls (P <.05 for mailed or telephone versus 
control).
Preventive Care Visits by Study Group
For all ages combined, 65% of mailed, 63% of telephone, and 59% of control group 
adolescents had a preventive care visit (P <.05 for mailed or telephone vs control), with a 
hazard ratio of 1.2 for the mailed group and 1.1 for the telephone group (Table 4). The 
mailed and telephone groups did not differ significantly. Of note, preventive visits declined 
in the control group from 63% (Table 1) to 59% (Table 3) as adolescents aged; this age-
related secular trend was not noted in the mailed or telephone groups. The number needed to 
treat for an additional preventive care visit was 17 for mailed reminders and 29 for telephone 
reminders.
Subgroup Analyses
We performed subgroup analyses to assess whether the reminder/recall interventions had 
greater effects for certain ages, gender, insurance types, practice types, or suburban, urban, 
or rural residence. We adjusted subgroup confidence intervals for the multiple comparisons 
within each outcome. We did not find substantial differences for the effect of either mailed 
or telephone reminder on subgroups (data not shown), ie, the magnitude of the effects was 
similar across subgroups to the effects for the entire groups.
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Analysis for Entire Plan Population
We reanalyzed findings for the entire sample of 7404 adolescents (ie, including the 40.9% or 
adolescents with missing telephone numbers and the 3.6% of adolescents with no 
geocodable addresses) (Tables 3, 4). The impact of the mailed reminders was nearly 
identical but the impact of telephone reminders was blunted.
Process Measures
Only 56 (6%) of the 1431 mailed reminder letters were returned. For 388 (27%) households 
in the telephone reminder group, the reminder call was unanswered or was picked up by 
voice mail.
Missed Opportunities—Table 5 compares missed opportunities across study groups. 
Both mailed and telephone groups had slightly fewer missed opportunities than controls for 
any vaccinations.
Costs—The total cost of the intervention excluding research costs (excluding adolescents 
without telephone numbers or geocodable addresses) was $26,220 for the mailed component 
(52% personnel costs) and $23,738 for the telephone component (50% personnel costs). 
Thus, among all adolescents who received a reminder (n = 1396 mailed group and n = 1423 
telephone), the cost averaged $18.78 or $16.68 per adolescent per year for mailed and 
telephone reminders, respectively. Among the adolescents who actually received a targeted 
preventive care reminder/recall message, the cost per “additional” adolescent fully 
vaccinated was $463.99 for mailed and $714.98 for telephone groups, and the cost per 
“additional” adolescent receiving a preventive care visit was $324.75 for mailed and 
$487.03 for telephone groups.
Discussion
In this clinical trial of a centralized reminder/recall system based in a large managed care 
organization for the publicly insured, mailed letter reminders and telephone reminders to 
parents of adolescents improved rates of immunizations and preventive care visits a modest 
amount. The interventions had similar impact regardless of patient or practice 
characteristics. The annual cost for mailed and telephone reminders was also modest.
This study is novel in 3 ways: we evaluated a centralized automated immunization reminder/
recall system based in managed care, we focused on adolescent vaccines, and we also 
included reminders for adolescent preventive care visits. Although recent studies of practice-
based reminder/recall had limited effectiveness for low-income children,23–26 we found a 
modest impact on both adolescent immunization rates and on preventive care visits. An 
important question involves the level of impact needed for an intervention that promotes 
immunizations and preventive care visits to be considered “clinically significant” or 
worthwhile when applied across a large population. Because of the importance of 
vaccination and preventive services to the health of the individual and community, we 
believe an improvement of several percentage points is significant. Of note, the return on 
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investment is difficult to calculate because it involves multiple benefits from added 
immunizations plus preventive visits, with benefits potentially accruing across many years.
More intensive tiered outreach-based interventions16,27–30 have demonstrated greater impact 
on immunization rates than we noted in the current study, but these interventions are also 
more costly. Thus, although centralized reminder/recall can improve immunizations and 
preventive visits to some extent, more intensive interventions may be needed to raise rates 
even further, especially in hard-to-reach populations. This is particularly important for HPV 
vaccine because 3 vaccinations are required, spaced over time. Also, centralized reminder/
recall systems based in managed care plans can impact only patients enrolled in those plans. 
Centralized systems based in immunization registries might have even greater reach44 but 
need further study.45 Finally, because missed opportunities for immunizations occurred 
frequently, provider-based strategies such as provider prompts may be needed to eliminate 
missed opportunities during primary care visits.5
Although patient reminder/recall is widely recommended, a challenge to both practice-based 
and centrally-based reminder/recall is the lack of accurate telephone numbers or addresses 
which limited the potential “reach” of our intervention to about half the eligible population. 
One lesson is that practices and managed care organizations should make special efforts to 
update contact information during every contact with families— health care visits or re-
enrollment into health insurance plans. Although there is substantial interest in newer 
methods for sending reminders, such as text messages or emails, there is only scant evidence 
of their effectiveness46,47 and practical barriers to their use including continued dependence 
on accurate contact information and the need to opt in to receive text messages.8
Our study unveils a potentially new type of intervention to improve the receipt of preventive 
care among vulnerable populations—that is, centrally located automated patient reminder/
recall. Managed care organizations can take advantage of economies of scale with their 
ability to generate large numbers of letters using sophisticated mailing systems or telephone 
calls using autodialers. Managed care organizations typically use HEDIS to measure their 
quality performance48; because HEDIS now includes adolescent immunizations and 
adolescent preventive care visits, managed care plans have an incentive to improve rates. 
Furthermore, in New York and some other states and potentially under the Affordable Care 
Act, Medicaid managed care plans can receive additional quality incentive payments based 
on achieving certain quality metrics.49 A managed-care based centralized, automated 
reminder/recall system to improve rates of vaccination and preventive visits may have a 
place in multipronged efforts to optimize preventive care services for adolescents.
Although we hypothesized that telephone reminders would work better than mailed 
reminders, mailed reminders performed slightly better than telephone reminders. It is 
possible that remembering verbal rather than printed instructions is challenging. Telephone 
messages may not necessarily reach the household decision-maker or may be erased if left 
on an answering machine. At the same time, low literacy among the target population might 
limit the potential impact of mailed reminders despite low-reading level messages and 
Spanish versions. The results of this study may temper expectations for the degree to which 
automated patient reminder/recall can improve preventive care services.
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Finally, although the impact of our intervention was modest, so was the cost, which 
averaged $18.78 for mailed and $16.68 for telephone reminders per adolescent per year. 
Importantly, the cost per additional adolescent vaccinated was higher than the cost per 
additional individual vaccinated reported in some studies50–52 but in the range of other 
studies17,53 and less than the costs for stepped reminder/outreach interventions27,28; also the 
benefits involved both improved immunizations and greater preventive care visits.
Study strengths include the use of a clinically relevant intervention, a large and diverse 
sample, a broad spectrum of primary care practices, important outcomes (immunization rates 
and preventive visits), and a randomized controlled trial design. Our study was unique by 
focusing on low-income adolescents served by managed care; many studies of patient 
reminders have targeted families of young children,7,23,24,26 adult patients,7,30 privately 
insured populations,52,54 or have emanated from primary care practices rather than 
centralized organizations such as managed care plans. Our analysis of both the group 
missing telephone numbers and the entire adolescent age group highlights the real-world 
dilemma of reaching a low-income population with reminders. Our cost-effectiveness 
analysis of reminders complements the literature on cost-effectiveness of adolescent 
vaccinations themselves.55–57
One limitation to generalizability is that baseline immunization rates were lower than in 
some areas; benefits of the intervention could wane as rates rise. However, baseline 
preventive visit rates mirrored national rates.5,58 Second, this study had substantial research 
support, and we consider it an efficacy trial.59 Further implementation and dissemination 
studies are needed to assess continued effectiveness. Third, the managed care organization 
lacked telephone numbers for 41% of the population due to an apparent problem with 
download of data from NYS Medicaid enrollment files. Analysis of baseline data suggested 
that missing telephones were not the result of some biased enrollment or inclusion in our 
study. Finally, the intervention took place in a managed care organization that serves 
publicly insured, low-income families; findings may differ for higher-income populations or 
in settings with more accurate addresses and telephone numbers.
Conclusion
A centralized patient reminder/recall system using either mailed or telephone reminders, 
based in a managed care organization serving publicly insured patients, improved rates of 
immunization and preventive care visits. The impact of the intervention was modest, but 
costs were relatively low. Clinicians, public health leaders, managed care, or integrated 
health systems should consider centralized patient reminder/recall systems for low-income 
adolescents. Further research should assess the effectiveness and cost-effectiveness of these 
interventions in other settings.
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We assessed the impact of a managed care-based patient reminder/recall system on 
improving adolescent immunizations and preventive care visits. Mailed or telephone 
reminders improved immunization and preventive care visit rates by 4–9 percentage 
points, for a relatively modest cost.
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Flow diagram for study. As a secondary analysis, we included in an analysis all adolescents 
who were randomized, that is, including those with no phone or a bad address: controls (n = 
2406), mailed reminder (n = 2494), and telephone reminder (n = 2504).
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Table 1
Baseline Characteristics, Immunization Rates and Preventive Care Visit Rates by Randomization Group
Characteristics Control (n = 1296) Mailed Reminders (n = 
1396)
Telephone Reminders (n = 
1423)
Age, mean (SD), years, no. (%) 14.4 (2.0) 14.5 (2.0) 14.4 (2.0)
  11 178 (14) 210 (15) 222 (16)
  12 195 (15) 181 (13) 224 (16)
  13 190 (15) 194 (14) 196 (14)
  14 196 (15) 199 (14) 183 (13)
  15 186 (14) 230 (16) 206 (14)
  16 192 (15) 218 (16) 226 (16)
  17 159 (12) 164 (12) 166 (12)
Male, no. (%) 640 (49) 714 (51) 724 (51)
Insurance, no. (%)
  Medicaid managed care 602 (46) 686 (49) 628 (44)
  SCHIP 694 (54) 710 (51) 795 (56)
Practice specialty, no. (%)
  Pediatric 973 (75) 1053 (75) 1045 (73)
  Family medicine 296 (23) 318 (23) 338 (24)
  Internal medicine 27 (2) 25 (2) 40 (3)
Residence, no. (%)
  Urban/suburban 970 (81) 1017 (80) 1026 (79)
  Rural 228 (19) 250 (20) 271 (21)
Baseline immunization, no. (%)
  MCV4 838 (65) 917 (66) 904 (64)
  Tdap 998 (78) 1073 (77) 1083 (77)
  HPV 1 416 (63) 463 (68) 480 (69)
  HPV 2 335 (51) 370 (54) 373 (53)
  HPV 3 229 (35) 260 (38) 255 (36)
  All vaccinations (girls-includes HPV) 551 (43) 625 (45) 605 (43)
Preventive care visit rates in previous 12 mo, no. (%)
  All ages 815 (63%) 922 (66%) 917 (64%)
  11 136 (76) 155 (74) 178 (80)
  12 133 (68) 125 (69) 146 (65)
  13 107 (56) 125 (64) 123 (63)
  14 121 (62) 134 (67) 107 (58)
  15 121 (65) 154 (67) 122 (59)
  16 114 (59) 136 (62) 141 (62)
  17 83 (52) 93 (57) 100 (60)
SCHIP = NY State Child Health Insurance Program; MCV4 = meningococcal vaccine; Tdap = pertussis vaccine; HPV = human papillomavirus 
vaccine.
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